These stocks have gained 10,000% over the last few decades. What lessons do they hold for finding the next 100-bagger?
Which clinical-stage biotech stock wins in a head-to-head match-up between Agenus and Alnylam?
Data from a competitor gives investors hope that the company's drug will have a larger potential market.
Both of these semiconductor stocks come with some challenges, but one has far more risk than the other.
Bargain-hunters can start off the year by taking a deeper look at these three promising healthcare stocks.
Intel, Qualcomm, and Texas Instruments haven't rallied as much as NVIDIA this year, but they all offer more appealing dividends for income investors.
Looking for cheap biotech stocks you can buy now? These three may be bargains.
Want to add some dividends to your portfolio in December? Check out Amgen, Gilead Sciences, American Tower, Enterprise Products Partners, and Albemarle Corporation.
November is coming to an end, but it isn’t too late to buy shares of Applied Materials, TSMC, or Qualcomm.
The Soros Fund showed a healthy appetite for biotech stocks in Q3 -- ignoring the political risk.